Complete Filing Data
Morgan Stanley Direct Lending Fund reported Stock Issued During Period Value Dividend Reinvestment Plan of $0.00 for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Morgan Stanley Direct Lending Fund did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income Loss | $122.1M | $215.6M | $231.0M | $48.5M | $83.3M |
| Interest Expense | $136.1M | $122.9M | $112.9M | $67.2M | $21.0M |
| Other General And Administrative Expense | $359.0K | $97.0K | $633.0K | $510.0K | $1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | $27.6M | $36.1M | $29.7M | $53.2M | $59.0M | $51.7M | $73.4M | $56.4M | $43.8M | $9.4M | -$3.3M | $22.2M |
| Interest Expense | $33.9M | $34.7M | $34.2M | $33.2M | $29.3M | $27.3M | $29.7M | $27.9M | $26.7M | $18.6M | $13.8M | $10.3M |
| Other General And Administrative Expense | $38.0K | $128.0K | $182.0K | $120.0K | $51.0K | $108.0K | $118.0K | $197.0K | $168.0K | $351.0K | $67.0K | $410.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $1.75B | $1.84B | $1.72B | $1.40B | $1.19B | $301.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $81.4M | $63.4M | $69.7M | $81.2M | $74.2M | $11.3M |
| Stockholders Equity Period Increase Decrease | -$94.1M | $121.0M | $323.8M | $208.7M | $887.0M | |
| Debt And Equity Securities Unrealized Gain Loss | $32.8M | -$80.0M | $8.4M | |||
| Debt And Equity Securities Realized Gain Loss | $118.0K | $537.0K | $1.9M | |||
| Interest Income Operating Paid In Cash | $396.4M | $355.5M | $223.1M | $108.3M | ||
| Repayments Of Long Term Debt | $1.45B | $712.0M | $438.0M | $1.28B | $598.0M | |
| Dividends Accrued But Not Yet Paid | $43.2M | $53.2M | $50.0M | $33.1M | $29.7M | |
| Amortization Of Deferred Financing Costs | $4.1M | $3.7M | $3.2M | $3.7M | $2.9M | |
| Accretion Amortization Of Discounts And Premiums Investments | $15.7M | $14.9M | $11.3M | $11.4M | $10.1M | |
| Retained Earnings Accumulated Deficit | -$19.6M | $29.6M | $8.5M | -$54.8M | ||
| Receivable Investment Sale | $455.0K | $470.0K | $173.0K | $188.0K | ||
| Management Fee Payable | $9.6M | $7.0M | $2.0M | $1.8M | ||
| Long Term Debt | $2.09B | $1.97B | $1.50B | $1.52B | ||
| Liabilities And Stockholders Equity | $3.92B | $3.91B | $3.31B | $2.99B | ||
| Liabilities | $2.17B | $2.07B | $1.59B | $1.59B | ||
| Interest Payable Current And Noncurrent | $20.9M | $21.2M | $18.8M | $17.0M | ||
| Dividends Payable Current And Noncurrent | $43.2M | $53.2M | $50.0M | $33.1M | ||
| Deferred Finance Costs Net | $10.5M | $6.5M | $5.6M | $7.9M | ||
| Debt Issuance Costs Line Of Credit Arrangements Net | $16.9M | $16.5M | $14.3M | $7.6M | ||
| Common Stock Value | $86.0K | $89.0K | $83.0K | $71.0K | ||
| Cash And Cash Equivalents At Carrying Value | $81.4M | $63.4M | $69.7M | $81.2M | ||
| Assets | $3.92B | $3.91B | $3.31B | $2.99B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.77B | $1.79B | $1.82B | $1.85B | $1.86B | $1.84B | $1.48B | $1.44B | $1.41B | $1.31B | $1.24B | $1.19B | $1.24B | $1.19B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $65.5M | $52.2M | $69.4M | $90.4M | $95.0M | $64.8M | $88.1M | $52.9M | $99.6M | $59.9M | $80.8M | $38.9M | ||
| Stockholders Equity Period Increase Decrease | -$18.7M | -$27.5M | -$24.3M | -$8.2M | $24.9M | $115.9M | $41.5M | $25.4M | $17.3M | $66.3M | $50.0M | $2.3M | ||
| Debt And Equity Securities Unrealized Gain Loss | -$17.1M | $5.4M | $2.8M | $2.7M | $22.8M | $8.6M | -$567.0K | -$24.4M | -$33.1M | -$4.3M | ||||
| Debt And Equity Securities Realized Gain Loss | $549.0K | -$11.0M | $108.0K | -$5.6M | $5.0K | $0.00 | $122.0K | $18.0K | $465.0K | $74.0K | ||||
| Interest Income Operating Paid In Cash | $105.1M | $99.1M | $94.6M | $91.0M | $86.6M | $81.7M | $60.8M | $48.5M | $42.7M | |||||
| Repayments Of Long Term Debt | $163.0M | $112.0M | $0.00 | $443.0M | ||||||||||
| Dividends Accrued But Not Yet Paid | $44.1M | $44.4M | $35.7M | $27.5M | ||||||||||
| Amortization Of Deferred Financing Costs | $960.0K | $926.0K | $699.0K | $1.1M | ||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $4.3M | $2.7M | $2.5M | $2.0M | ||||||||||
| Retained Earnings Accumulated Deficit | -$7.9M | $7.9M | $15.3M | $29.8M | $30.0M | $15.7M | -$475.0K | -$30.7M | -$46.4M | |||||
| Receivable Investment Sale | $14.8M | $134.0K | $364.0K | $1.9M | $136.0K | $348.0K | $22.0K | $621.0K | $91.0K | |||||
| Management Fee Payable | $9.6M | $9.6M | $9.0M | $6.8M | $6.5M | $5.1M | $1.9M | $1.9M | $1.8M | |||||
| Long Term Debt | $2.07B | $2.05B | $2.01B | $1.84B | $1.66B | $1.49B | $1.72B | $1.55B | $1.58B | |||||
| Liabilities And Stockholders Equity | $3.93B | $3.92B | $3.91B | $3.79B | $3.66B | $3.40B | $3.28B | $3.07B | $3.06B | |||||
| Liabilities | $2.16B | $2.13B | $2.09B | $1.94B | $1.79B | $1.56B | $1.80B | $1.63B | $1.65B | |||||
| Interest Payable Current And Noncurrent | $22.2M | $16.2M | $16.4M | $16.3M | $20.7M | $9.0M | $8.9M | $18.9M | $9.3M | |||||
| Dividends Payable Current And Noncurrent | $43.5M | $43.6M | $44.1M | $53.5M | $44.7M | $44.4M | $43.2M | $41.0M | $35.7M | |||||
| Deferred Finance Costs Net | $11.2M | $8.8M | $5.6M | $7.4M | $8.3M | $5.0M | $6.2M | $6.7M | $7.3M | |||||
| Debt Issuance Costs Line Of Credit Arrangements Net | $17.9M | $18.9M | $19.8M | $17.5M | $17.0M | $13.4M | $15.3M | $10.1M | $10.9M | |||||
| Common Stock Value | $87.0K | $87.0K | $88.0K | $89.0K | $89.0K | $89.0K | $72.0K | $71.0K | $71.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $65.5M | $52.2M | $69.4M | $90.4M | $95.0M | $64.8M | $88.1M | $52.9M | $99.6M | |||||
| Assets | $3.93B | $3.92B | $3.91B | $3.79B | $3.66B | $3.40B | $3.28B | $3.07B | $3.06B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Proceeds From Issuance Of Long Term Debt | $1.55B | $1.19B | $408.0M | $1.57B | $1.51B |
| Proceeds From Issuance Of Common Stock | -$163.0K | $95.9M | $222.8M | $254.6M | $854.6M |
| Proceeds From Disposition Of Investment Operating Activity And Increase Decrease In Receivable For Investment Sold Or Repaid | $771.9M | $657.2M | $362.5M | $393.8M | $384.5M |
| Payments Of Dividends | $184.0M | $169.1M | $110.5M | $85.7M | $38.2M |
| Payments Of Deferred Financing Costs | $4.5M | $5.9M | $9.9M | $4.0M | $8.2M |
| Payments For Purchase Of Investment Operating Activity And Increase Decrease In Payable For Investment Purchased | $771.6M | $1.23B | $632.1M | $945.2M | $2.11B |
| Net Cash Provided By Used In Operating Activities | $150.9M | -$382.5M | -$83.8M | -$429.8M | -$1.66B |
| Net Cash Provided By Used In Financing Activities | -$132.9M | $376.2M | $72.3M | $436.9M | $1.72B |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $51.0K | $132.0K | $13.0K | -$228.0K | $70.0K |
| Increase Decrease In Management Fee Payable | $2.6M | $5.0M | $229.0K | $477.0K | $1.0M |
| Increase Decrease In Interest Payable Net | -$260.0K | $2.4M | $1.8M | $13.7M | $2.1M |
| Increase Decrease In Incentive Fee Payable | -$1.7M | -$2.8M | $3.6M | -$541.0K | $5.8M |
| Increase Decrease In Due To Affiliates | $62.0K | -$2.8M | $784.0K | -$2.3M | $2.6M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.5M | $1.6M | $826.0K | $44.0K | $1.2M |
| Increase Decrease In Interest And Dividends Receivable | $1.7M | $8.0M | $9.2M | $9.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Proceeds From Issuance Of Long Term Debt | $193.0M | $102.0M | $60.0M | $554.5M |
| Proceeds From Issuance Of Common Stock | $0.00 | $95.9M | $2.6M | $7.8M |
| Proceeds From Disposition Of Investment Operating Activity And Increase Decrease In Receivable For Investment Sold Or Repaid | $201.9M | $71.5M | $90.2M | $28.5M |
| Payments Of Dividends | $53.1M | $37.2M | $23.9M | $22.2M |
| Payments Of Deferred Financing Costs | $4.3M | $0.00 | $3.9M | $2.1M |
| Payments For Purchase Of Investment Operating Activity And Increase Decrease In Payable For Investment Purchased | $203.7M | $165.4M | $139.6M | $177.7M |
| Net Cash Provided By Used In Operating Activities | $34.1M | -$53.7M | -$16.4M | -$125.2M |
| Net Cash Provided By Used In Financing Activities | -$37.1M | $48.7M | $34.8M | $89.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.7M | $247.0K | $448.0K | $129.0K |
| Increase Decrease In Management Fee Payable | $1.9M | $3.1M | $43.0K | $240.0K |
| Increase Decrease In Interest Payable Net | -$4.8M | -$9.9M | -$7.7M | $1.9M |
| Increase Decrease In Incentive Fee Payable | $512.0K | -$1.6M | $1.3M | -$1.5M |
| Increase Decrease In Due To Affiliates | -$18.0K | -$359.0K | -$694.0K | -$1.5M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.7M | -$596.0K | $107.0K | -$287.0K |
| Increase Decrease In Interest And Dividends Receivable | $457.0K | $1.6M | $86.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 87.3M | 88.6M | 74.2M | 61.7M | 31.2M | 7.6M | |
| Investment Company Investment Income Loss Per Share | $2.02 | $2.48 | $2.67 | $2.08 | $2.34 | $1.41 | |
| Weighted Average Number Of Diluted Shares Outstanding | 87.3M | 88.6M | 74.2M | 61.7M | 31.2M | 7.6M | |
| Net Asset Value Per Share | $20.26 | $20.81 | $20.67 | $19.81 | $20.91 | $20.08 | $20.00 |
| Earnings Per Share Diluted | $1.40 | $2.43 | $3.11 | $0.79 | $2.67 | ||
| Earnings Per Share Basic | $1.40 | $2.43 | $3.11 | $0.79 | $2.67 | ||
| Common Stock Shares Outstanding | 86.3M | 88.5M | 83.3M | 70.5M | 56.8M | 15.0M | |
| Common Stock Shares Issued | 86.3M | 88.5M | 83.3M | 70.5M | |||
| Common Stock Shares Authorized | 500.0M | 500.0M | 100.0M | 100.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 86.8M | 87.2M | 88.4M | 89.3M | 89.3M | 87.4M | 71.9M | 71.3M | 70.9M | 64.1M | 59.2M | 57.1M |
| Investment Company Investment Income Loss Per Share | $0.50 | $0.50 | $0.52 | $0.66 | $0.63 | $0.63 | $0.70 | $0.67 | $0.62 | $0.53 | $0.50 | $0.46 |
| Weighted Average Number Of Diluted Shares Outstanding | 86.8M | 87.2M | 88.4M | 89.3M | 89.3M | 87.4M | 71.9M | 71.3M | 70.9M | 64.1M | 59.2M | 57.1M |
| Net Asset Value Per Share | $20.41 | $20.83 | $20.83 | $20.67 | $20.57 | $20.15 | $19.93 | $20.00 | $20.32 | $20.82 | ||
| Earnings Per Share Diluted | $0.32 | $0.41 | $0.34 | $0.60 | $0.66 | $0.59 | $1.02 | $0.79 | $0.62 | $0.15 | $-0.06 | $0.39 |
| Earnings Per Share Basic | $0.32 | $0.41 | $0.34 | $0.60 | $0.66 | $0.59 | $1.02 | $0.79 | $0.62 | $0.15 | $-0.06 | $0.39 |
| Common Stock Shares Outstanding | 86.8M | 87.0M | 88.0M | 89.0M | 89.4M | 88.9M | 72.0M | 71.5M | 71.0M | 65.4M | 61.1M | 57.2M |
| Common Stock Shares Issued | 86.8M | 87.0M | 88.0M | 89.0M | 89.4M | 88.9M | 72.0M | 71.5M | 71.0M | |||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stock Issued During Period Value Dividend Reinvestment Plan | $0.00 | $23.4M | $41.9M | $30.3M | $13.6M |
| Stock Issued During Period Value New Issues | -$163.0K | $95.8M | $220.2M | $94.6M | $862.5M |
| Investment Income Operating After Expense And Tax | $176.0M | $220.2M | $198.1M | $128.0M | $72.9M |
| Investment Company Dividend Distribution | $174.0M | $195.7M | $169.3M | $119.4M | $72.3M |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$53.9M | -$4.7M | $33.0M | -$79.5M | $10.3M |
| Professional Fees | $8.0M | $6.7M | $4.5M | $3.2M | $2.4M |
| Noninterest Expense Directors Fees | $517.0K | $533.0K | $345.0K | $362.0K | $336.0K |
| Net Investment Income | $178.8M | $222.7M | $199.6M | $128.3M | $73.0M |
| Management Fee Expense | $38.5M | $35.4M | $30.6M | $26.7M | $13.9M |
| Investment Income Investment Expense | $219.5M | $209.4M | $191.1M | $122.2M | $57.1M |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $218.4M | $193.4M | $168.2M | $102.2M | $46.8M |
| Gross Investment Income Operating | $397.3M | $416.1M | $367.7M | $230.6M | $119.8M |
| Investment Company Capital Share Transaction And Dividend Distribution Increase Decrease | -$42.1M | $101.2M | $262.1M | $279.6M | $876.0M |
| Income Based Incentive Fee Expense | $43.5M | $42.0M | $26.6M | $15.9M | |
| Administrative Fees Expense | $287.0K | $216.0K | $178.0K | $72.0K | $212.0K |
| Other Income | $6.4M | $5.8M | $4.4M | $10.1M | |
| Interest Income Operating Paid In Kind | $10.7M | $4.3M | $1.6M | $1.0M | |
| Dividend Income Operating | $2.6M | $2.1M | $1.5M | $409.0K | |
| Reinvestment Of Dividend Distributions | $0.00 | $23.4M | $41.9M | $30.3M | $13.6M |
| Interest Paid Net | $126.6M | $113.0M | $105.3M | $48.6M | $15.0M |
| Interest And Dividend Income Operating Paid In Kind | $18.2M | $13.1M | $6.1M | $2.7M | $1.2M |
| Capital Gains Incentive Fee Expense Reversal | $0.00 | $0.00 | -$2.4M | $1.8M | |
| Excise Taxes Paid Net | $2.6M | $1.5M | $361.0K | $57.0K | $5.0K |
| Investment Company Contractual Fee Waived | $22.9M | $20.0M | $10.4M | ||
| Amortization Of Financing Costs And Discounts | $5.0M | $3.9M | $2.5M | $1.6M | $0.00 |
| Investment Income Operating Tax Expense Benefit | $2.8M | $2.4M | $1.5M | $334.0K | $80.0K |
| Investment Company Expense Offset Arrangement | $0.00 | $0.00 | -$44.0K | -$98.0K | |
| Investment Owned At Fair Value | $3.77B | $3.79B | $3.19B | $2.87B | |
| Investment Owned At Cost | $3.84B | $3.81B | $3.23B | $2.94B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Dividend Reinvestment Plan | $0.00 | $0.00 | $0.00 | $0.00 | $10.6M | $12.8M | $11.3M | $9.7M | $8.9M | $7.6M | $7.0M | $7.5M | |
| Stock Issued During Period Value New Issues | -$40.0K | -$123.0K | $0.00 | $0.00 | $0.00 | $95.8M | $0.00 | $0.00 | $0.00 | $79.8M | $74.9M | ||
| Investment Income Operating After Expense And Tax | $43.7M | $43.7M | $46.2M | $58.7M | $56.1M | $54.7M | $50.6M | $47.8M | $44.2M | $33.8M | $29.4M | $26.5M | |
| Investment Company Dividend Distribution | $43.4M | $43.5M | $44.0M | $53.4M | $44.7M | $44.4M | $43.2M | $40.7M | $35.4M | $30.6M | $28.6M | $27.5M | |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$16.1M | -$7.6M | -$16.6M | -$5.5M | $2.9M | -$3.0M | $22.8M | $8.6M | -$445.0K | -$24.4M | -$32.7M | -$4.3M | |
| Professional Fees | $2.5M | $1.7M | $1.6M | $1.7M | $1.7M | $1.2M | $1.3M | $847.0K | $1.2M | $923.0K | $776.0K | $624.0K | |
| Noninterest Expense Directors Fees | $129.0K | $130.0K | $129.0K | $130.0K | $128.0K | $146.0K | $85.0K | $88.0K | $80.0K | $87.0K | $88.0K | $87.0K | |
| Net Investment Income | $44.1M | $43.9M | $46.9M | $59.2M | $56.6M | $55.1M | $50.6M | $47.8M | $44.2M | $33.8M | $29.4M | $26.5M | |
| Management Fee Expense | $9.6M | $9.6M | $9.6M | $9.1M | $8.6M | $8.2M | $7.8M | $7.4M | $7.3M | $6.9M | $6.5M | $6.2M | |
| Investment Income Investment Expense | $55.6M | $55.7M | $55.6M | $54.5M | $51.4M | $48.3M | $49.7M | $46.7M | $44.9M | $34.1M | $25.5M | $22.4M | |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $55.6M | $55.7M | $54.6M | $50.5M | $47.6M | $44.0M | $43.9M | $41.1M | $39.4M | $28.9M | $20.6M | $17.8M | |
| Gross Investment Income Operating | $99.7M | $99.5M | $101.5M | $109.8M | $104.2M | $99.1M | $94.5M | $88.9M | $83.6M | $62.7M | $50.0M | $44.3M | |
| Investment Company Capital Share Transaction And Dividend Distribution Increase Decrease | -$2.9M | -$20.1M | -$10.0M | -$8.0M | $10.6M | $108.6M | $11.3M | $9.7M | $8.9M | $56.8M | $53.2M | ||
| Income Based Incentive Fee Expense | $9.8M | $10.1M | $11.6M | $11.3M | $10.7M | $10.1M | $9.4M | $7.2M | $5.9M | $5.5M | |||
| Administrative Fees Expense | $81.0K | $85.0K | $60.0K | $138.0K | $17.0K | $25.0K | $27.0K | $60.0K | $54.0K | $54.0K | $54.0K | $16.0K | |
| Other Income | $1.8M | $1.6M | $1.3M | $1.8M | $1.2M | $985.0K | $976.0K | $1.0M | $1.0M | ||||
| Interest Income Operating Paid In Kind | $2.2M | $2.9M | $2.6M | $1.1M | $622.0K | $441.0K | $506.0K | $277.0K | $272.0K | ||||
| Dividend Income Operating | $670.0K | $646.0K | $565.0K | $564.0K | $504.0K | $496.0K | $439.0K | $232.0K | $309.0K | ||||
| Reinvestment Of Dividend Distributions | $0.00 | $12.8M | $8.9M | $7.5M | |||||||||
| Interest Paid Net | $36.9M | $35.6M | $33.1M | $6.5M | |||||||||
| Interest And Dividend Income Operating Paid In Kind | $4.9M | $3.2M | $1.0M | $370.0K | |||||||||
| Capital Gains Incentive Fee Expense Reversal | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$1.7M | -$747.0K | |||||
| Excise Taxes Paid Net | $2.6M | $1.5M | $361.0K | $57.0K | |||||||||
| Investment Company Contractual Fee Waived | $5.8M | $5.6M | $5.5M | $5.1M | $4.9M | $4.6M | |||||||
| Amortization Of Financing Costs And Discounts | $1.1M | $635.0K | $628.0K | $177.0K | |||||||||
| Investment Income Operating Tax Expense Benefit | $402.0K | $200.0K | $627.0K | $2.4M | $501.0K | $500.0K | $436.0K | $0.00 | $0.00 | $0.00 | |||
| Investment Company Expense Offset Arrangement | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$39.0K | |||||||
| Investment Owned At Fair Value | $3.78B | $3.79B | $3.79B | $3.64B | $3.51B | $3.29B | $3.12B | $2.98B | $2.93B | ||||
| Investment Owned At Cost | $3.84B | $3.83B | $3.83B | $3.66B | $3.54B | $3.32B | $3.16B | $3.04B | $2.99B |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.